ASHG 2019

Recent articles

RNA, transcription

Antidote to ‘poison’ DNA may treat lethal form of epilepsy

An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.

By Nicholette Zeliadt
26 August 2020 | 3 min read

Brain ‘organoids’ point to new drug target for fragile X syndrome

New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.

By Nicholette Zeliadt
18 October 2019 | 3 min read
Illustration of a DNA strand.

Massive project doubles list of genes tied to autism

The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.

By Nicholette Zeliadt
17 October 2019 | 3 min read

Explore more from The Transmitter

Psilocybin rewires specific mouse cortical networks in lasting ways

Neuronal activity induced by the psychedelic drug strengthens inputs from sensory brain areas and weakens cortico-cortical recurrent loops.

By Siddhant Pusdekar
5 December 2025 | 0 min watch

Home makeover helps rats better express themselves: Q&A with Raven Hickson and Peter Kind

The “Habitat”—a complex environment with space for large social groups—expands the behavioral repertoire of rodent models, Hickson and Kind say.

By Holly Barker
4 December 2025 | 0 min watch

Tatiana Engel explains how to connect high-dimensional neural circuitry with low-dimensional cognitive functions

Neuroscientists have long sought to understand the relationship between structure and function in the vast connectivity and activity patterns in the brain. Engel discusses her modeling approach to discovering the hidden patterns that connect the two.

By Paul Middlebrooks
3 December 2025 | 1 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.